Lot-document scope confirmed before quotation · Research use only
  • Specification Review
  • Lot Documents on Request
  • Business Support · Xi’an
  • Destination Eligibility Confirmed
西安诺和达生物科技有限公司

Research & insights

Epitalon Identity Guide: AEDG Sequence, Mass and Evidence Boundary

By NHD Technical TeamPublished Updated Sep 8, 2026

Epitalon is the tetrapeptide Ala-Glu-Asp-Gly, abbreviated AEDG. Identity, sequence confirmation, chromatographic purity and quantitative peptide content are related but separate measurements.

Evidence at a glance

  • PubChem lists sequence AEDG, formula C14H22N4O9 and molecular weight 390.35 g/mol.
  • Epitalon, Epithalon and Epithalone appear as synonyms, but Epithalamin refers to a different historical extract context and should not be collapsed automatically.
  • A purity percentage does not report water, residual solvents, counterions or absolute peptide content.
Documentary HPLC laboratory scene for an Epitalon identity guide
AI-generated editorial illustration illustrating an analytical workflow. It does not depict a supplied product, released lot, approved formulation or assay result.

Identity record

The four-residue order and stereochemistry define the reference compound. A certificate should state the molecular form used for mass calculations and whether the reported amount is on an as-is, anhydrous or peptide-content basis.

SequenceAla-Glu-Asp-Gly / AEDG
FormulaC14H22N4O9
Molecular weight390.35 g/mol
PubChemCID 219042
Core lot checksSequence or intact mass, chromatography, content basis, water, residual solvents and lot linkage

Analytical and evidence boundary

Mass spectrometry supports molecular identity while chromatography estimates separation of major components. Neither test alone establishes biological activity, sterility, endotoxin, stability or suitability for a particular experimental system.

Product copy should use “studied in cell-aging and mouse-oocyte models.” It should not use “extends lifespan,” “reverses aging” or similar language without direct controlled human outcome evidence.

Editorial rule

State the exact material, form, model or population and endpoint supported by the cited record. Do not convert mechanistic plausibility, an animal result, an official finished-drug label or an analytical test into a claim about an unrelated catalog lot.

Sources & editorial method

This article discusses the source records listed below, with the study models and limitations stated alongside the findings. AI-assisted drafting and image generation were used. The reference list identifies the records behind this article; it is not an independent peer review or verification of a supplied catalog lot.

3 linked records are listed in the references below. Read the editorial and AI-assistance policy.

How to interpret this article

Source-checked on 2026-09-02. Null results, sample size, model/population limits and regulatory scope are retained. This is not medical advice, a customer case or validation of a catalog lot.

Research-use boundary: Catalog materials discussed on this website are for laboratory research, development and manufacturing use only, not for human or veterinary use. This content is not medical advice and does not provide administration instructions.

Primary records and authoritative sources

  1. Epitalon and telomere length in human cell linesCell study. 2025. PMID 40908429.
  2. Epitalon delays postovulatory aging of mouse oocytesPreclinical study. 2022. PMID 35413689.
  3. PubChem Epitalon recordSequence, formula, molecular weight and synonyms; CID 219042.
Research pathways

Continue with structured records

Move from this editorial analysis to the product identity, filtered evidence and controlled terminology behind it.

Editorial source check: Site evidence editorial team · 2026-09-02